Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
Quantitative Sensory Testing (QST) - Does assessing ... - TI Pharma
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
4. <strong>QST</strong> and neuropathic pain mechanisms<br />
Fig. 4-2: Mechanical Pain Sensitivity (MPS) stimulus-response functions for neuropathic pain<br />
patients (n=24). Patients with MPS z-score values outside of the 95% CI showed an absence<br />
of stimulus-response function to pinpricks. Stimulus-response functions were assessed by<br />
seven pinpricks exerting forces of 8mN, 16mN, 32mN, 64mN, 128mN, 256mN and 512mN.<br />
Each data point represents mean value for numerical rating scale (NRS (0-100)) for the painfulness<br />
of five stimulations for each pinprick force.<br />
3.4. Clinical diagnoses of patients with MPS abnormalities and different<br />
stimulus-response functions for pinpricks<br />
All patients with MPS abnormalities have been diagnosed with neuropathic pain.<br />
Patients with stimulus-response function for MPS included peripheral nerve injury<br />
(n=13), complex regional pain syndrome (CRPS)-II (n=1) and central pain (n=2). Similar<br />
clinical entities are reflected in the group of patients with a lack of a stimulus-response<br />
function for MPS. In this group, patients were diagnosed with peripheral nerve injury<br />
(n=14), polyneuropathy (n=6), central pain (n=3) and postherpatic neuralgia (n=1).<br />
Disease duration for each of these two groups ranged between 1 year and 15 years.<br />
Similar clinical entities of neuropathic pain patients were for both groups of MPS<br />
abnormalities indicating that the phenomenon of different responder to pinprick pain is<br />
not restricted to the clinical entity.